| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 23 |
| 1 | METHOTREXATE | 20 |
| 2 | METHOTREXATE SODIUM | 20 |
| 3 | CYCLOPHOSPHAMIDE | 15 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 15 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 15 |
| 6 | PANTOPRAZOLE | 14 |
| 7 | CARBOPLATIN | 13 |
| 8 | INFLIXIMAB | 13 |
| 9 | PREDNISONE | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TEDIZOLID PHOSPHATE | 2 | 0.0025 |
| 1 | AMPICILLIN AND SULBACTAM | 2 | 0.0023 |
| 2 | BECLOMETHASONE DIPROPIONATE | 7 | 0.0012 |
| 3 | PYRIDOSTIGMINE BROMIDE ORAL | 3 | 0.0008 |
| 4 | AMPICILLIN SODIUM AND SULBACTAM SODIUM | 2 | 0.0008 |
| 5 | INSULIN DEGLUDEC AND LIRAGLUTIDE | 1 | 0.0006 |
| 6 | ROPEGINTERFERON ALFA-2B | 1 | 0.0005 |
| 7 | SILODOSIN | 2 | 0.0005 |
| 8 | CEMIPLIMAB-RWLC | 1 | 0.0005 |
| 9 | ZANAMIVIR | 1 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interferon alfa-2b [EPC] | 1 | 0.0005 |
| 1 | Neuraminidase Inhibitor [EPC] | 1 | 0.0004 |
| 2 | Programmed Death Ligand-1 Blocker [EPC] | 5 | 0.0002 |
| 3 | CTLA-4-directed Blocking Antibody [EPC] | 6 | 0.0001 |
| 4 | Cannabinoid [EPC] | 1 | 0.0001 |
| 5 | Dietary Cholesterol Absorption Inhibitor [EPC] | 11 | 0.0001 |
| 6 | Microtubule Inhibitor [EPC] | 18 | 0.0001 |
| 7 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 10 | 0.0001 |
| 8 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 | 0.0001 |
| 9 | Antimalarial [EPC] | 1 | 0.0001 |